51243f73-e34f-5ecb-ad63-c3edad617198

‘Wild West’ peptide craze surges beyond GLP-1s as FDA faces pressure to ease access

The peptide market is surging alongside GLP-1 demand, creating tension between compounding pharmacies and commercial drug companies over patient access.